Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hLF1-11 in Staphylococcus Epidermidis Bacteremia
NCT00509847Phase 2Withdrawn
- Sponsor
- AM-Pharma
- Start
- Feb 2009
- Primary completion
- Jul 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of human lactoferrin peptide 1-11 in Staphylococcus epidermidis bacteremia, sponsored by AM-Pharma. Planned start Feb 2009; status: withdrawn.
02
Drugs
human lactoferrin peptide 1-11
03
Conditions
Staphylococcus epidermidis bacteremia
Beyond the preview
Go deeper on NCT00509847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00509847.